1. Home
  2. MEC vs ANNX Comparison

MEC vs ANNX Comparison

Compare MEC & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mayville Engineering Company Inc.

MEC

Mayville Engineering Company Inc.

HOLD

Current Price

$18.52

Market Cap

345.2M

Sector

Industrials

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.95

Market Cap

334.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEC
ANNX
Founded
1945
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
345.2M
334.1M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
MEC
ANNX
Price
$18.52
$4.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$22.00
$16.60
AVG Volume (30 Days)
216.0K
3.6M
Earning Date
11-04-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$533,523,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
$31.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.72
$1.29
52 Week High
$19.25
$5.66

Technical Indicators

Market Signals
Indicator
MEC
ANNX
Relative Strength Index (RSI) 65.49 69.84
Support Level $16.81 $4.01
Resistance Level $19.25 $5.34
Average True Range (ATR) 0.79 0.28
MACD 0.21 0.03
Stochastic Oscillator 79.94 68.80

Price Performance

Historical Comparison
MEC
ANNX

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: